Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026)
Hims & Hers Health (HIMS) posted Change in Accured Expenses of $10.0 million for Q1 2026, up 625.22% sequentially from -$1.9 million in Q4 2025, and up 130.2% YoY from $4.4 million in Q1 2025.
Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Change in Accured Expenses for 8 years, with the latest figure at $10.0 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 130.2% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$37.4 million (down 222.99% YoY) and the FY2025 annual result came in at -$43.1 million, down 280.96% from the prior year.
- Change in Accured Expenses rose to $10.0 million in Q1 2026 per HIMS's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $14.0 million in Q3 2024 and troughed at -$52.9 million in Q3 2025.
- A 5-year average of $481588.2 and a median of $3.3 million in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses plunged 565.29% in 2022, then surged 507.26% in 2024.
- Over 5 years, Change in Accured Expenses stood at -$4.6 million in 2022, then surged by 134.96% to $1.6 million in 2023, then soared by 507.26% to $9.8 million in 2024, then sank by 119.48% to -$1.9 million in 2025, then surged by 625.22% to $10.0 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $10.0 million, -$1.9 million, and -$52.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.50 Bn | 6.66 Bn | 480.80 Mn | 79.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.51 Mn |
| Jun 30, 2026 | 79.51 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Dec 31, 2025 | -1.91 Mn |
| Sep 30, 2025 | -52.88 Mn |
| Sep 30, 2025 | -52.88 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Jun 30, 2025 | 7.39 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Mar 31, 2025 | 4.35 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Dec 31, 2024 | 9.79 Mn |
| Sep 30, 2024 | 14.03 Mn |
| Sep 30, 2024 | 14.03 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.23 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |